Trial Details
COMPLETEDBasic Information
| Clinical ID | c307 |
|---|---|
| Identifier | NCT01666327 |
| Trial Title | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | DRUG: MT-1303 |
Participant Information
| Sponsor | Mitsubishi Tanabe Pharma Corporation |
|---|---|
| City | Nottingham |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-06-12 |
|---|---|
| Primary Completion Date | 2025-07-14 |
| Completion Date | 2025-07-14 |